PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F12XT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $278,086
Award facts
- Contract value 100% obligated
- $278,086.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $278,086.34, was awarded on January 8, 2026, to AmerisourceBergen Drug Corp, the corporate office division of Cencora, Inc., by the Defense Logistics Agency's Medical Supply Chain. The contract is firm fixed-price with an ultimate completion date of January 9, 2026, and will be performed in Conshohocken, Pennsylvania, the company's headquarters location. The award represents a non-set-aside, competitively awarded delivery order under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at up to $1 billion through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. Through its federal contract portfolio, the company supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities, including medications such as Trulicity, Ozempic, Vraylar, and Lyrica, as well as ancillary medical supplies. The Defense Logistics Agency is currently planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, potentially involving at least three different contractors, demonstrating the strategic importance of pharmaceutical supply chain management across the Department of Defense and its healthcare systems.
Quick answers
Who was awarded contract SPE2D826F12XT?
SPE2D826F12XT was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 8, 2026.
How much is contract SPE2D826F12XT worth?
The government has obligated $278,086 on SPE2D826F12XT.
Is contract SPE2D826F12XT an order under another contract?
Yes. SPE2D826F12XT is a delivery order under SPE2DX22D0029, an indefinite delivery contract.
Was contract SPE2D826F12XT competed?
The extent of competition for SPE2D826F12XT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award